CENTRAL ADIPOSITY MARKERS: PREDICTING GLUCOSE METABOLISM DISORDERS AND ANDROLOGICAL HEALTH IMPLICATIONS IN YOUNG MEN BEYOND WEIGHT
Main Article Content
Keywords
Anthropometry, Body Mass Index, Fasting Blood Glucose, Diabetes, Male Hypogonadism, Testosterone, Metabolic Health.
Abstract
Objective: To examine the relationship between anthropometric indicators and fasting blood glucose (FBG) levels in young adult males and assess their potential impact on andrological health.
Methodology: This cross-sectional study was conducted from March 2024 to September 2024. One hundred ninety-six young males aged 18-40 years were recruited using convenient purposive sampling. Anthropometric measurements included body mass index (BMI), waist circumference, waist-to-height ratio (WHtR), waist-to-hip ratio (WHR), mid-upper arm circumference (MUAC), body fat percentage, and visceral fat levels. Fasting blood glucose was measured after an 8-hour overnight fast. Prediabetes was defined as FBG 100-125 mg/dL, and diabetes as FBG ≥126 mg/dL. Data were analyzed using SPSS version 25.0.
Results: The average age was 30.1 ± 5.8 years, with 63% living in urban areas. The overall prevalence of prediabetes was 20.4% (40 out of 196). The mean BMI was 23.9±3.5 kg/m², and the mean FBG was 94.8 ± 9.2 mg/dL. Significant correlations were found between FBG and age (r=0.198, p<0.01) and BMI (r=0.175, p<0.05). Overweight participants had significantly higher mean FBG compared to those with normal weight (97.3 vs. 93.2 mg/dL, difference=4.1 mg/dL, p<0.05).
Conclusion: The high prevalence of prediabetes (20.4%) in young males and its link to anthropometric indicators have important implications for andrological health. Given the established connections between glucose metabolism disorders, obesity, and testosterone deficiency, these findings highlight the need for early screening that addresses both metabolic and reproductive health in young men.
References
2. Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, et al. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl. 2011;34(6 Pt 1):528-40.
3. Siddiqui M, Hameed R, Nadeem M, Mohammad T, Simbak N, Latif A, et al. Obesity in Pakistan: current and future perceptions. J Curr Trend Biomed Eng Biosci. 2018;17(2):555958.
4. Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, et al. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33(6):1186-92.
5. Kalyani RR, Dobs AS. Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes. 2007;14(3):226-34.
6. Lee CM, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008;61(7):646-53.
7. Basit A, Fawwad A, Qureshi H, Shera AS; NDSP Members. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017. BMJ Open. 2018;8(8):e020961.
8. Corona G, Giorda CB, Cucinotta D, Guida P, Nada E; SUBITO-DE Study Group. Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors. J Sex Med. 2014;11(8):2065-73.
9. Dandona P, Dhindsa S. Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab. 2011;96(9):2643-51.
10. Zumoff B, Strain GW, Miller LK, Rosner W, Senie R, Seres DS, et al. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab. 1990;71(4):929-31.
11. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295(11):1288-99.
12. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab. 2005;90(5):2636-41.
13. Isidori AM, Caprio M, Strollo F, Moretti C, Frajese G, Isidori A, et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab. 1999;84(10):3673-80.
14. Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95(4):1810-8.
15. Brand JS, Wareham NJ, Dowsett M, Folkerd E, van der Schouw YT, Luben RN, et al. Associations of endogenous testosterone and SHBG with glycated haemoglobin in middle-aged and older men. Clin Endocrinol (Oxf). 2011;74(5):572-8.
16. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Valkonen VP, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004;27(5):1036-41.
17. Selvin E, Feinleib M, Zhang L, Rohrmann S, Rifai N, Nelson WG, et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care. 2007;30(2):234-8.
18. Basit A, Fawwad A, Siddiqui SA, Baqa K. Current management strategies to target the increasing incidence of diabetes within Pakistan. Diabetes Metab Syndr Obes. 2019;12:85-96.
19. Pencina KM, Travison TG, Artz AS, Bhasin S, Brito JP, Cunningham GR, et al. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(10):e2340030.
20. Yassin A, Haider A, Haider KS, Caliber M, Doros G, Saad F, et al. Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study. Diabetes Care. 2019;42(6):1104-11.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Noman Sadiq
PhD Scholar, Physiology, Sindh University, Jamshoro
Jamshed Warsi
Associate Professor, Physiology, Sindh University, Jamshoro
Muhammad Afzal
Associate Professor, ENT, Mekran Medical College, Turbat
Mukhtiar Ahmed
Assistant Professor, Pathology, Jhalawan Medical College, Khuzdar.
Muhammad Tahir
Associate Professor, Pharmacology, HBS Medical and Dental College, Islamabad
Shabeer Ahmed
Assistant Professor, Physiology, Mekran Medical College, Turbat.